The rising prevalence in GLP-1 agonists for diabetes has led to a discussion about formats: patches versus pills . Usually , GLP-1 therapies were only available in pill form, but the emergence of https://philipudmg375855.diowebhost.com/96154302/glp-1-transdermal-delivery-systems-vs-tablets-which-suitable-for-the-patient